Sullano, Peter S.
HRN: 25-54-72 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/26/2024
CEFAZOLIN 1GM (VIAL)
07/26/2024
08/02/2024
IV
1g
Q8H
Fracture, Abrasions
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes